These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32135582)

  • 1. Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus.
    Sung MJ; Lim TS; Jeon MY; Lee HW; Kim BK; Kim DY; Ahn SH; Han KH; Park JY; Kim SU
    Gut Liver; 2020 Sep; 14(5):626-635. PubMed ID: 32135582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Sarcopenia in an Obese Asian Population.
    Sung MJ; Park JY; Lee HW; Kim BK; Kim DY; Ahn SH; Kim SU
    Nutr Cancer; 2022; 74(2):505-514. PubMed ID: 33733940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
    Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
    Han E; Lee YH; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Kim SU
    Aliment Pharmacol Ther; 2018 Aug; 48(3):300-312. PubMed ID: 29920701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases.
    Hyun Kim K; Kyung Kim B; Yong Park J; Young Kim D; Hoon Ahn S; Han KH; Kim SU
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):58-65. PubMed ID: 31283527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients.
    Giorda CB; Forlani G; Manti R; Mazzotti A; De Cosmo S; Rossi MC; Nicolucci A; Di Bartolo P; Ceriello A; Guida P; Tartaglino B; Russo G;
    Diabetes Res Clin Pract; 2018 Jan; 135():65-72. PubMed ID: 29097288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A High Fibrosis-4 Index is Associated with a Reduction in the Estimated Glomerular Filtration Rate in Non-obese Japanese Patients with Type 2 Diabetes Mellitus.
    Inoue H; Asahara SI; Nakamura F; Kido Y
    Kobe J Med Sci; 2024 Apr; 70(1):E39-E45. PubMed ID: 38719339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease.
    Chun HS; Kim MN; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
    J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1168-1178. PubMed ID: 34337887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.
    Seo DH; Lee YH; Park SW; Choi YJ; Huh BW; Lee E; Huh KB; Kim SH; Cha BS
    Diabetes Metab; 2020 Oct; 46(5):362-369. PubMed ID: 31689496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
    Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
    Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.
    Wijarnpreecha K; Kim D; Raymond P; Scribani M; Ahmed A
    Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1121-1128. PubMed ID: 30888971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.
    Han E; Lee YH; Kim YD; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Nam HS; Heo JH; Kim SU
    Am J Gastroenterol; 2020 Apr; 115(4):584-595. PubMed ID: 32141917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years.
    Lee HW; Lee JS; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
    J Diabetes Complications; 2021 Jan; 35(1):107747. PubMed ID: 33616043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011).
    Hong KS; Kim MC; Ahn JH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1005-1014. PubMed ID: 32440112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
    J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle-aged patients with non-alcoholic fatty liver disease.
    Tada T; Toyoda H; Sone Y; Yasuda S; Miyake N; Kumada T; Tanaka J
    J Gastroenterol Hepatol; 2019 Nov; 34(11):2011-2018. PubMed ID: 31115065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes.
    Aller de la Fuente R; Mora Cuadrado N; Tafur C; López Gómez JJ; Gómez de la Cuesta S; García Sánchez MC; Antolin Melero B; de Luis Román DA
    Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(6):354-360. PubMed ID: 29477355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications.
    Ciardullo S; Muraca E; Perra S; Bianconi E; Zerbini F; Oltolini A; Cannistraci R; Parmeggiani P; Manzoni G; Gastaldelli A; Lattuada G; Perseghin G
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and diabetes mellitus are associated with high FIB-4 index in a health checkup examination cohort without known liver disease.
    Sato S; Kawai H; Sato S; Iwasaki H; Omori M; Kita Y; Ikeda Y; Awatsu T; Murata A; Taniguchi G; Shimada Y; Genda T
    BMC Gastroenterol; 2022 Nov; 22(1):478. PubMed ID: 36411436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.